Healthcare -
Biotechnology - NASDAQ - US
$ 38.6444
-0.118 %
$ 10.8 B
Market Cap
21.96
P/E
EXEL - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities EXEL - Exelixis, Inc.
-117 M
LAST VALUE
52.81%
2 YEAR CAGR
27.60%
5 YEAR CAGR
-6.04%
10 YEAR CAGR